MIRM Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: November 07, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Mirum Pharmaceuticals Inc (MIRM)

Based on 16 analysts giving stock ratings to Mirum Pharmaceuticals Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
38
Buy
56
Hold
6
Sell
0
Strong Sell
0
Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals Inc. Stock Analysis MIRM

United States Health Care Mid Cap Report:
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Foster City, California and currently employs 355 full-time employees. The company went IPO on 2019-07-18. The firm is focused on the treatment of rare diseases affecting children and adults. The company has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The firm is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.
Read More

Mirum Pharmaceuticals Inc (MIRM) Chart

Mirum Pharmaceuticals Inc (MIRM) vs CBOE Volatility Index (VIX) Comparative Returns

Analysis of Mirum Pharmaceuticals Inc (MIRM) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.

YTD Performance
  • Mirum Pharmaceu... (MIR...) 29.14%
  • CBOE Volatility Index (VIX) 7.42%
Mirum Pharmaceu... Outperformed CBOE Volatility Index (VIX) by 21.72%
1Y Performance
  • Mirum Pharmaceu... (MIR...) 101.12%
  • CBOE Volatility Index (VIX) -3.02%
Mirum Pharmaceu... Outperformed CBOE Volatility Index (VIX) by 104.14%
3Y Performance
  • Mirum Pharmaceu... (MIR...) 333.35%
  • CBOE Volatility Index (VIX) -19.46%
Mirum Pharmaceu... Outperformed CBOE Volatility Index (VIX) by 352.81%
5Y Performance
  • Mirum Pharmaceu... (MIR...) 385.76%
  • CBOE Volatility Index (VIX) -51.47%
Mirum Pharmaceu... Outperformed CBOE Volatility Index (VIX) by 437.23%

Key Statistics of Mirum Pharmaceuticals Inc (MIRM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$99.80$103.42

Today's Open

$100.82

Volume

505.79K

P/E Ratio (TTM)

-

52 Week Range

$36.88$105.74

Market Cap

5.33B

Avg. Volume

710.37K

Dividend Yield

-

Financial Metrics & Statements of Mirum Pharmaceuticals Inc (MIRM)

Super Investors Invested in Mirum Pharmaceuticals Inc (MIRM)

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

FAQ's for Mirum Pharmaceuticals Inc (MIRM)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.